Status:
COMPLETED
Understanding Patient Perspectives on the Risks of Ionizing Radiation Used for Medical Imaging
Lead Sponsor:
Memorial Sloan Kettering Cancer Center
Conditions:
Breast Cancer
Colon Cancer
Eligibility:
All Genders
18+ years
Brief Summary
Risks from imaging-related radiation exposure have become a popular topic in the media. Because these tests are commonly applied to patients at a cancer center, it is important to understand what pati...
Eligibility Criteria
Inclusion
- English-language fluent
- 18 years of age, or older
- Provide informed consent
- Group 1: Patients undergoing chemotherapy for Stage IV colorectal carcinoma.
- Group 2: Parents of pediatric patients who have undergone treatment for stage 1-3 neuroblastoma.
- Group 3: Women who have undergone treatment for early stage breast cancer within the preceding 6 months.
- Group 4: Men undergoing surveillance imaging after treatment for testicular cancer.
- Group 5: Patients currently or previously enrolled in the MSKCC lung cancer screening program.
- Group 6: Patients enrolled in or eligible for the thoracic survivorship program.
Exclusion
- Participants who don't speak English
Key Trial Info
Start Date :
November 1 2011
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
June 1 2015
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT01482741
Start Date
November 1 2011
End Date
June 1 2015
Last Update
June 25 2015
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Memorial Sloan Kettering Cancer Center
New York, New York, United States, 10065